Vericel Corp Ord (VCEL)

Exchange
NASDAQ
Symbol
VCEL
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: March 7, 2025

  • Open
    48.43
  • High
    50.36
  • Low
    47.08
  • Close
    49.56
  • Volume
    459,530

Financial ratios

Dec 31, 2023